TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years October 20, 1978
TCL Archive In Brief: Coalition Dinner Celebrates NCI’s 50th Anniversary, Honors Lasker, Three Ex-Senators September 18, 1987
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
